返回 Agenda
Closing Session: Summary of Take-a-Ways and Calls to Action
Session Chair(s)
Julie Ann Rosenberg, MD
Development Asset Lead, Oncology Biosimilars, Pfizer Essential Health
Pfizer, Inc., United States
Closing Session: Summary of Take-a-Ways and Calls to Action